community download

Presentation: Julianna Lisziewicz

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Dr Julianna Lisziewicz, the President, CEO and Vice President of Research, GeneticImmunity joined us at the 12th annual World Vaccine Congress Washington in April 2012 to talk about GeneticImmunity’s very interesting take on personalizing vaccines. Dr Lisziewicz talked us through her views on why we need to personalize DermaVir and other therapeutic vaccines and presented the DPM concept and its details to the audience, using DermaVir as the first example.

Of course any novel technology needs to be fully tested for safety and efficacy and Dr Lisziewicz did present safety and preliminary efficacy of repeated DermaVir immunizations of phase II results from the US and EU. The results show the challenges and potential solutions in the development of DPM.
Why not download the full presentation and discover more about Digital Personal Medicine.